SCHEMBL7146898

SCHEMBL7146898

COc1ccc(-c2ccc(Cl)cc2)n2nc(N)nc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 3/20 0.51
HPGD P15428 3/20 0.51
HSD17B10 Q99714 2/20 0.51
NPC1 O15118 2/20 0.51
TP53 P04637 1/20 0.51
GLA P06280 1/20 0.51
GAA P10253 1/20 0.51
RAB9A P51151 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
TUBB4A P04350 1/20 0.51
TUBB P07437 1/20 0.51
TUBA3C P0DPH7 1/20 0.51
TUBA1B P68363 1/20 0.51
TUBA4A P68366 1/20 0.51
TUBB4B P68371 1/20 0.51
TUBB3 Q13509 1/20 0.51
TUBB2A Q13885 1/20 0.51
TUBB8 Q3ZCM7 1/20 0.51
TUBA3E Q6PEY2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7043078 0.87 JAK1 (0.60) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL7144538 0.87 PDE4D (0.49) KDM4EALDH1A1HPGDHSD17B10TUBB4A
SCHEMBL2257907 0.86 MAPT (0.49) KDM4EALDH1A1HPGDPDE4DJAK1
SCHEMBL2250839 0.86 PDE4D (0.64) KDM4EPDE4DJAK1PDE10A
SCHEMBL7146570 0.84 PDE4D (0.48) NPC1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7143153 0.84 PDE4D (0.46) KDM4EALDH1A1HPGDTUBB4ATUBB
SCHEMBL7851265 0.79 PDE10A (0.44) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL6875680 0.78 PDE10A (0.44) NPC1RAB9ATUBB4ATUBBTUBA3C
SCHEMBL7148123 0.78 NUDT1 (0.55) ALDH1A1HSD17B10NPC1TP53RAB9A
SCHEMBL7145674 0.77 PDE10A (0.50) HPGDHSD17B10RAB9AMAPK1PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed